Individualized Screening Interval for Prostate Cancer Based on Prostate-Specific Antigen Level

200590 citationsJournal Articlegreen Open Access

Authors

Gunnar Aus · Sahlgrenska University Hospital

Jan‐Erik Damber · Sahlgrenska University Hospital

Ali Khatami · Memorial Sloan Kettering Cancer Center

Hans Lilja · Lund University

Johan Stranne · Malmö University

Jonas Hugosson · Memorial Sloan Kettering Cancer Center

Abstract

Retesting intervals should be individualized on the basis of the PSA level, and the large group of men with PSA levels of less than 1 ng/mL can safely be scheduled for a 3-year testing interval.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Urologic and reproductive health conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Internal Medicine

Volume 165, Issue 16, pp. 1857-1857

DOI: 10.1001/archinte.165.16.1857

Field-Weighted Citation Impact: 4.95